Cargando…
Aluminium adjuvants and adverse events in sub-cutaneous allergy immunotherapy
Sub-cutaneous immunotherapy is an effective treatment for allergy. It works by helping to modify or re-balance an individual’s immune response to allergens and its efficacy is greatly improved by the use of adjuvants, most commonly, aluminium hydroxide. Aluminium salts have been used in allergy ther...
Autor principal: | Exley, Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898727/ https://www.ncbi.nlm.nih.gov/pubmed/24444186 http://dx.doi.org/10.1186/1710-1492-10-4 |
Ejemplares similares
-
Aluminium in Allergies and Allergen immunotherapy
por: Jensen-Jarolim, Erika
Publicado: (2015) -
Unraveling the enigma: elucidating the relationship between the physicochemical properties of aluminium-based adjuvants and their immunological mechanisms of action
por: Shardlow, Emma, et al.
Publicado: (2018) -
Insight into the cellular fate and toxicity of aluminium adjuvants used in clinically approved human vaccinations
por: Mold, Matthew, et al.
Publicado: (2016) -
Unequivocal identification of intracellular aluminium adjuvant in a monocytic THP-1 cell line
por: Mold, Matthew, et al.
Publicado: (2014) -
Elevated brain aluminium and early onset Alzheimer’s disease in an individual occupationally exposed to aluminium: a case report
por: Exley, Christopher, et al.
Publicado: (2014)